News and Updates

Discover how new clinical trial designs for iPSC-derived heart cells are shaping the future of regenerative cardiovascular medicine and regulatory compliance.

Are FDA-cleared AI tools truly improving patient care? Explore the disconnect between regulatory approval and real-world clinical performance outcomes.

New mRNA vaccine trial data shows promising results for melanoma patients. Learn how personalized immunotherapy is changing skin cancer treatment.

The FDA has released new guidance on using digital measures in clinical trials, emphasizing data integrity, patient usability, and validation standards.

New research shows preoperative iron infusions significantly reduce blood transfusion needs and recovery complications in heart surgery patients.

A groundbreaking mRNA cancer vaccine has succeeded in a late-stage trial, offering a new personalized approach to destroying malignant tumors.

A breakthrough mRNA vaccine combined with immunotherapy significantly lowers melanoma recurrence, marking a major shift in personalized cancer treatment.

Space research is yielding new medical breakthroughs. Learn how a drug refined in orbit is now entering clinical trials to treat the rare Rett syndrome.

A biotech firm secures $36M to fund a late-stage Parkinson’s clinical trial, aiming to advance a new therapeutic candidate through the FDA approval process.

Discover how AI and machine learning are transforming clinical trial patient matching, reducing recruitment times, and accelerating medical breakthroughs.